Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials

Brady L. Stein*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science